Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Impaired DICER1 function promotes stemness and metastasis in colon cancer.

Iliou MS, da Silva-Diz V, Carmona FJ, Ramalho-Carvalho J, Heyn H, Villanueva A, Muñoz P, Esteller M.

Oncogene. 2014 Jul 24;33(30):4003-15. doi: 10.1038/onc.2013.398.

2.

Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.

Ju SY, Chiou SH, Su Y.

Stem Cell Res. 2014 Jan;12(1):86-100. doi: 10.1016/j.scr.2013.09.011.

3.

A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.

Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S Jr, Shiekhattar R, Esteller M.

Nat Genet. 2009 Mar;41(3):365-70. doi: 10.1038/ng.317. Erratum in: Nat Genet. 2010 May;42(5):464. Retraction in: Nat Genet. 2016 Feb;48(2):221.

4.

MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer.

Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, Wang X, Zhao Q, Ding J, Wu K, Fan D.

J Cell Mol Med. 2011 Sep;15(9):1887-95. doi: 10.1111/j.1582-4934.2010.01194.x.

5.

Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.

Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.

Cancer Lett. 2011 Aug 1;307(1):26-36. doi: 10.1016/j.canlet.2011.03.012.

6.

Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.

Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W.

Gastroenterology. 2013 Aug;145(2):426-36.e1-6. doi: 10.1053/j.gastro.2013.04.004.

PMID:
23583431
7.

L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.

Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze'ev A.

Mol Cancer Res. 2011 Jan;9(1):14-24. doi: 10.1158/1541-7786.MCR-10-0406.

8.

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.

Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X, Wan XP.

Med Oncol. 2013 Mar;30(1):484. doi: 10.1007/s12032-013-0484-0.

PMID:
23392577
10.

Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.

Pizzini S, Bisognin A, Mandruzzato S, Biasiolo M, Facciolli A, Perilli L, Rossi E, Esposito G, Rugge M, Pilati P, Mocellin S, Nitti D, Bortoluzzi S, Zanovello P.

BMC Genomics. 2013 Aug 29;14:589. doi: 10.1186/1471-2164-14-589.

11.

Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis.

Davalos V, Moutinho C, Villanueva A, Boque R, Silva P, Carneiro F, Esteller M.

Oncogene. 2012 Apr 19;31(16):2062-74. doi: 10.1038/onc.2011.383.

12.

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR.

PLoS One. 2012;7(10):e46514. doi: 10.1371/journal.pone.0046514.

13.

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.

Bao B, Ahmad A, Kong D, Ali S, Azmi AS, Li Y, Banerjee S, Padhye S, Sarkar FH.

PLoS One. 2012;7(8):e43726. doi: 10.1371/journal.pone.0043726.

14.

Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.

Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7.

PMID:
21750907
15.

Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß.

Qian NS, Liu WH, Lv WP, Xiang X, Su M, Raut V, Chen YL, Dong JH.

PLoS One. 2013 Aug 2;8(8):e68004. doi: 10.1371/journal.pone.0068004.

16.

Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549.

Lin S, Sun JG, Wu JB, Long HX, Zhu CH, Xiang T, Ma H, Zhao ZQ, Yao Q, Zhang AM, Zhu B, Chen ZT.

Mol Cells. 2012 Mar;33(3):277-83. doi: 10.1007/s10059-012-2252-y.

17.

AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.

Shi Z, Zhang J, Qian X, Han L, Zhang K, Chen L, Liu J, Ren Y, Yang M, Zhang A, Pu P, Kang C.

Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280.

18.

Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.

Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH.

Hepatology. 2014 Aug;60(2):598-609. doi: 10.1002/hep.27118.

PMID:
24616020
19.

Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.

Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM.

Oncogene. 2014 Feb 6;33(6):702-12. doi: 10.1038/onc.2013.13.

20.

Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.

Ren D, Wang M, Guo W, Zhao X, Tu X, Huang S, Zou X, Peng X.

Int J Oncol. 2013 Apr;42(4):1473-81. doi: 10.3892/ijo.2013.1825.

PMID:
23404342
Items per page

Supplemental Content

Support Center